RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 50.47

Change

-0.21 (-0.41)%

Market Cap

N/A

Volume

1.70K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-1.98 (-6.25%)

USD 11.50B
QLD ProShares Ultra QQQ

-0.31 (-0.28%)

USD 7.95B
FNGU MicroSectors FANG+ Index 3X Le..

+1.65 (+0.31%)

USD 5.90B
SSO ProShares Ultra S&P500

+0.10 (+0.10%)

USD 5.68B
UPRO ProShares UltraPro S&P500

+0.12 (+0.13%)

USD 4.34B
TECL Direxion Daily Technology Bull..

-0.57 (-0.59%)

USD 3.15B
YINN Direxion Daily FTSE China Bull..

-0.20 (-0.71%)

USD 2.02B
USD ProShares Ultra Semiconductors

-2.21 (-3.08%)

USD 1.40B
LABU Direxion Daily S&P Biotech Bul..

-2.08 (-1.58%)

USD 0.99B
DPST Direxion Daily Regional Banks ..

-2.87 (-1.91%)

USD 0.88B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
ASWA:XETRA European Green Deal UCITS.. 2.35 % 0.00 %

+0.03 (+0.45%)

USD 0.02B
VXM:CA First Asset Morningstar I.. 0.56 % 0.70 %

-0.38 (0.45%)

CAD 0.01B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

-0.33 (0.45%)

USD 0.10B
VXM-B:CA CI Morningstar Internatio.. 0.00 % 0.00 %

N/A

CAD 0.29B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.13 (0.45%)

USD 8.70B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+0.75 (+0.45%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.16 (+0.45%)

USD 0.24B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.04 (+0.45%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.43% 29% F 56% F
Dividend Return 1.69% 80% B- 32% F
Total Return 12.13% 30% F 52% F
Trailing 12 Months  
Capital Gain 24.96% 30% F 67% D+
Dividend Return 2.12% 60% D- 30% F
Total Return 27.08% 30% F 66% D+
Trailing 5 Years  
Capital Gain 76.51% 67% D+ 79% B-
Dividend Return 4.66% 74% C 11% F
Total Return 81.18% 68% D+ 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.72% 28% F 72% C
Dividend Return 12.94% 28% F 68% D+
Total Return 0.22% 22% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 30.99% 96% N/A 34% F
Risk Adjusted Return 41.77% 72% C 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.